Phillip Crews

15PUBLICATIONS

75CO-AUTHORS

Biomolecular modelling and designBiologically active moleculesHaematological tumoursForestry fire managementCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 17, 2026

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

|Sep 30, 2024

Further Probing the Properties of a Unique Sponge-derived Alkaloid Through the Isolation of a New (-)-(5E)-(8R)-(14Z)-Mycothiazole Analogue.

Joe A Gerke, Sofia F Odron, Juri Kim

|Dec 05, 2022

Reevaluation of a Bicyclic Pyrazoline as a Selective 15-Lipoxygenase V-Type Activator Possessing Fatty Acid Specificity.

Christopher van Hoorebeke, Kevin Yang, Samuel J Mussetter

|Sep 08, 2022

Appraising California Zinfandel Exposure to Wildfire Smoke Using Natural Product Phenolic Diglycoside Biomarkers.

Phillip Crews, Paul Dorenbach, Gabriella Amberchan

|Jul 09, 2022

In Vivo Evaluation of (-)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site.

Leila Takahashi-Ruiz, Joseph D Morris, Phillip Crews

|Mar 21, 2022

Re-evaluation of the Fijianolide/Laulimalide Chemotype Suggests an Alternate Mechanism of Action for C-15/C-20 Analogs.

Joseph D Morris, Leila Takahashi-Ruiz, Lauren N Persi

Pageof 3

Frequent Collaborators

Gabriella Amberchan

Joseph D Morris

Tyler A Johnson

Asmaa Boufridi

James B McAlpine

Shao-Nong Chen

Andrei Kutateladze

Giovanni Appendino

Andersson Barison

Mehdi A Beniddir

Frequent Collaborators

Gabriella Amberchan

Joseph D Morris

Tyler A Johnson

Asmaa Boufridi